Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implications for preterm
Helene Lacaille1, Ekaterina Lebayle2, Barbara Corneo2
1Division of Neonatology, Department of Pediatrics, Vagelos College of Physicians and Surgeons and New York-Presbyterian Morgan Stanley Children's Hospital, Columbia University, New York, NY, United States.
Abstract:
Preterm birth substantially elevates the risk of neurological and cognitive disorders. Recent evidence suggests that the abrupt loss of placental support, particularly the cessation of neurotrophic and neuroprotective hormones, alters neurodevelopmental trajectories and may contribute to neurodevelopmental risk associated with prematurity. Our study investigates how the placental steroid hormone, allopregnanolone (ALLO), affects cerebral cortex development using human cortical organoid models. Our findings reveal that while ALLO exposure produces modest effects on overall cortical development, its withdrawal specifically disrupts GABAergic but not glutamatergic neuronal development. These results demonstrate that placental hormones, including ALLO, may target specific neuronal populations critical for cortical function, identifying potential therapeutic interventions following placental loss in human preterm neonates.
More Related Videos
Related Concept Videos
Teratogenicity
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Drugs Affecting Neurotransmitter Synthesis


